The NEOMED Institute is a response to the changing pharma R&D business model. In view of the considerable gap between basic research and the commercialization of new drugs, we seek to create a bridge.

We provide industrial expertise in drug discovery and development combined with funding and a favourable ecosystem to transform innovations into solid therapeutic solutions. We drive drug discovery activities up to the stage of human proof of concept. This stage is an important turning point, where projects become attractive to the biopharmaceutical industry or can constitute the basis for the creation of solid start-up companies.

The NEOMED Institute is jointly funded by the pharmaceutical industry, the Ministère de l’Économie, de la Science et de l’Innovation du Québec, and the Networks of Centres of Excellence (NCE) of Canada.

    Sommaire du programme
For whom ? Researchers and companies
How much ? Depending on the program
What ? Venture funds
For what ? Projects with a high potential to impact biopharmaceutical research on its ability to address unmet needs

Development Phase


Phone: +1 514 367-1212

Web site:

7171 Frederick-Banting
Montréal, Québec
H4S 1Z9